| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 01/07/2004 | CN1465394A Medicine for treating oophoritic cyst and its preparation process |
| 01/07/2004 | CN1465358A Vagina girdle, clean and anti-inflamation agent for female |
| 01/07/2004 | CN1133637C Triptolide analogs and composition and use thereof |
| 01/07/2004 | CN1133636C Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 01/07/2004 | CN1133635C Cyanopyrroles as progesterone receptor agonists |
| 01/07/2004 | CN1133447C Pure Chinese medicine prepn. for fast strengthening yang and tonifying kidney |
| 01/07/2004 | CN1133442C Medicine for treating spermacrasia and its preparation process |
| 01/07/2004 | CN1133434C Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/06/2004 | US6673838 Succinate salt of O-desmethyl-venlafaxine |
| 01/06/2004 | US6673825 Urazole compounds useful as anti-inflammatory agents |
| 01/06/2004 | US6673796 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/06/2004 | US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 01/06/2004 | US6673377 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 01/06/2004 | US6673375 Mostly comprising sodium metasilicate (pentahydrate) and shows nonspecific immunostimulating activity in plants and animals |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/02/2004 | EP1374693A2 Method for preventing decrease of breast milk amount in mammals |
| 01/02/2004 | EP1373888A2 Method for screening for progesterone receptor isoform-specific ligands |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373266A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 01/02/2004 | EP1373242A1 Dimeric isoflavones |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373220A1 Benzimidazoles that are useful in treating sexual dysfunction |
| 01/02/2004 | EP1373217A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 01/02/2004 | EP1373205A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 01/02/2004 | EP1373203A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 01/02/2004 | EP1373192A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1373188A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 01/02/2004 | EP1372740A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/02/2004 | EP1372680A1 Biologically active aqueous fraction of an extract obtained from a mangrove plant salvadora persica l |
| 01/02/2004 | EP1372672A1 Prophylactic teat treatment |
| 01/02/2004 | EP1372665A2 Hormone replacement therapy method and its administration form |
| 01/02/2004 | EP1372664A1 Use of certain steroids for treatment of blood cell deficiencies |
| 01/02/2004 | EP1372656A1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 01/02/2004 | EP1372654A2 Quinoline inhibitors of hyak1 and hyak3 kinases |
| 01/02/2004 | EP1372653A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/02/2004 | EP1372625A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors |
| 01/02/2004 | EP1372605A2 Intravaginal drug delivery devices for the administration of an antimicrobial agent |
| 01/02/2004 | EP1203011B1 Orally active androgens |
| 01/02/2004 | EP0746343B1 Bioartificial kidney devices coated with cells suitable for use in vivo or ex vivo |
| 01/01/2004 | US20040002535 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 01/01/2004 | US20040002534 Stem cell factor; signal transduction passageways; anticancer agents |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002519 Mixture of hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, insulin elimination promoter and insulin sensitizer with carrier |
| 01/01/2004 | US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
| 01/01/2004 | US20040002508 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 01/01/2004 | US20040002507 Rho-kinase inhibitors |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 01/01/2004 | US20040002482 Androgen pharmaceutical composition and method for treating depression |
| 01/01/2004 | US20040002477 Therapy for sexual disorders; chealte compound with cyclodextrin |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002113 Detection and treatment methods for type I diabetes |
| 01/01/2004 | US20040001895 Combination treatment for depression and anxiety |
| 01/01/2004 | US20040001865 Methods for treating priapism |
| 01/01/2004 | US20040001824 Cell proliferation inhibitors |
| 12/31/2003 | WO2004000854A1 Sulfur-containing phospholipid derivatives |
| 12/31/2003 | WO2004000842A1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 12/31/2003 | WO2004000830A1 Novel compounds, their use and preparation |
| 12/31/2003 | WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/31/2003 | WO2004000816A1 Androgen receptor agonist |
| 12/31/2003 | WO2004000808A2 N-substituted piperidine derivatives as serotonin receptor agents |
| 12/31/2003 | WO2004000801A2 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 12/31/2003 | WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 12/31/2003 | WO2004000363A1 Process for producing sustained-release composition |
| 12/31/2003 | WO2004000361A1 Metastable pharmaceutical compositions |
| 12/31/2003 | WO2004000326A1 Combination therapy wherein a serotonin reuptake inhibitor is used |
| 12/31/2003 | WO2004000237A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 12/31/2003 | WO2004000230A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
| 12/31/2003 | WO2004000225A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 12/31/2003 | WO2004000205A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 12/31/2003 | WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 12/31/2003 | WO2003080021A3 Formulation comprising buprenorphine |
| 12/31/2003 | WO2003072055A3 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors |
| 12/31/2003 | WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia |
| 12/31/2003 | WO2003060475A3 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2002070562A3 Nuclear hormone receptor ligand binding domain |
| 12/31/2003 | WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
| 12/31/2003 | CN1464791A Compositions for protein delivery via the pulmonary route |
| 12/31/2003 | CN1464787A Novel hormone composition |
| 12/31/2003 | CN1463699A A composition for treating animal endometritis |
| 12/31/2003 | CN1132613C Anti-impotence kidney-tonifying capsule |
| 12/31/2003 | CN1132605C Chinese medicine for treating male sexual disfunction |
| 12/31/2003 | CN1132600C Baichun Prepn. for treating women's pelvic infection |
| 12/31/2003 | CN1132597C The active part of golden pheasant as one Chinese medicine material and its application in preparing medicinal composite |
| 12/31/2003 | CN1132589C Process for preparing plaster to promote circulation of blood and vital energy |
| 12/31/2003 | CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 12/31/2003 | CA2490397A1 N-substituted piperidine derivatives as serotonin receptor agents |
| 12/31/2003 | CA2490121A1 Modified phospholipids |
| 12/31/2003 | CA2490057A1 Metastable pharmaceutical compositions |
| 12/31/2003 | CA2489847A1 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 12/31/2003 | CA2489815A1 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |